TAYLOR SCHALL: Open Payments
NPI 1871941484 · PHILIPSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 20 payments from 12 companies in 2025. Trend: 2023 $367 · 2024 $224 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $93 |
| Novo Nordisk Inc | 4 | $71 |
| Lilly USA, LLC | 2 | $36 |
| PFIZER INC. | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: QULIPTA, Ozempic, MOUNJARO, NURTEC ODT, GEMTESA, SHINGRIX, SKYRIZI, REXULTI.
Industry payments across PA — which companies pay providers there.
